These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 28839853)

  • 1. A systematic approach to the management of cholestatic pruritus in primary biliary cirrhosis.
    Hegade VS; Bolier R; Oude Elferink RP; Beuers U; Kendrick S; Jones DE
    Frontline Gastroenterol; 2016 Jul; 7(3):158-166. PubMed ID: 28839853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pruritus secondary to primary biliary cholangitis: a review of the pathophysiology and management with phototherapy.
    Hussain AB; Samuel R; Hegade VS; Jones DE; Reynolds NJ
    Br J Dermatol; 2019 Dec; 181(6):1138-1145. PubMed ID: 30920648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis and Management of Pruritus in PBC and PSC.
    Kremer AE; Namer B; Bolier R; Fischer MJ; Oude Elferink RP; Beuers U
    Dig Dis; 2015; 33 Suppl 2():164-75. PubMed ID: 26641452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug treatment of pruritus in liver diseases.
    Hegade VS; Kendrick SF; Jones DE
    Clin Med (Lond); 2015 Aug; 15(4):351-7. PubMed ID: 26407384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Butorphanol as Treatment for Cholestatic Itch.
    Golpanian RS; Yosipovitch G; Levy C
    Dig Dis Sci; 2021 May; 66(5):1693-1699. PubMed ID: 32556969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial.
    Hegade VS; Kendrick SF; Dobbins RL; Miller SR; Richards D; Storey J; Dukes G; Gilchrist K; Vallow S; Alexander GJ; Corrigan M; Hirschfield GM; Jones DE
    BMC Gastroenterol; 2016 Jul; 16(1):71. PubMed ID: 27431238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitis.
    Kremer AE; Mayo MJ; Hirschfield G; Levy C; Bowlus CL; Jones DE; Steinberg A; McWherter CA; Choi YJ
    Liver Int; 2022 Jan; 42(1):112-123. PubMed ID: 34403559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholestatic pruritus: Emerging mechanisms and therapeutics.
    Patel SP; Vasavda C; Ho B; Meixiong J; Dong X; Kwatra SG
    J Am Acad Dermatol; 2019 Dec; 81(6):1371-1378. PubMed ID: 31009666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary biliary cirrhosis: safety and benefits of established and emerging therapies.
    Tabibian JH; Lindor KD
    Expert Opin Drug Saf; 2015; 14(9):1435-44. PubMed ID: 26212223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptoms of PBC - Pathophysiology and management.
    Khanna A; Leighton J; Lee Wong L; Jones DE
    Best Pract Res Clin Gastroenterol; 2018; 34-35():41-47. PubMed ID: 30343709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical strategies for pruritus management in the obeticholic acid-treated patient with PBC: proceedings from the 2018 expert panel.
    Pate J; Gutierrez JA; Frenette CT; Goel A; Kumar S; Manch RA; Mena EA; Pockros PJ; Satapathy SK; Yimam KK; Gish RG
    BMJ Open Gastroenterol; 2019; 6(1):e000256. PubMed ID: 30815273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial.
    de Vries E; Bolier R; Goet J; Parés A; Verbeek J; de Vree M; Drenth J; van Erpecum K; van Nieuwkerk K; van der Heide F; Mostafavi N; Helder J; Ponsioen C; Oude Elferink R; van Buuren H; Beuers U;
    Gastroenterology; 2021 Feb; 160(3):734-743.e6. PubMed ID: 33031833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholestatic pruritus : an update.
    De Vloo C; Nevens F
    Acta Gastroenterol Belg; 2019; 82(1):75-82. PubMed ID: 30888758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid is a potential mediator of cholestatic pruritus.
    Kremer AE; Martens JJ; Kulik W; Ruëff F; Kuiper EM; van Buuren HR; van Erpecum KJ; Kondrackiene J; Prieto J; Rust C; Geenes VL; Williamson C; Moolenaar WH; Beuers U; Oude Elferink RP
    Gastroenterology; 2010 Sep; 139(3):1008-18, 1018.e1. PubMed ID: 20546739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pruritus in primary biliary cholangitis is under-recorded in patient medical records.
    Gungabissoon U; Smith HT; von Maltzahn R; Logie J; Fairburn-Beech J; Ma L; P D; McGirr A; Hunnicutt JN; Rowe CL; Tierney M; Friedler HS
    BMJ Open Gastroenterol; 2024 Mar; 11(1):. PubMed ID: 38538090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of symptom complexes in primary biliary cholangitis.
    Kuo A; Kuo A; Bowlus CL
    Curr Opin Gastroenterol; 2016 May; 32(3):204-9. PubMed ID: 26825590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in pathogenesis and management of pruritus in cholestasis.
    Kremer AE; Bolier R; van Dijk R; Oude Elferink RP; Beuers U
    Dig Dis; 2014; 32(5):637-45. PubMed ID: 25034299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmapheresis exerts a long-lasting antipruritic effect in severe cholestatic itch.
    Krawczyk M; Liebe R; Wasilewicz M; Wunsch E; Raszeja-Wyszomirska J; Milkiewicz P
    Liver Int; 2017 May; 37(5):743-747. PubMed ID: 27778443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging drugs for the treatment of primary biliary cholangitis.
    Phaw NA; Dyson JK; Jones D
    Expert Opin Emerg Drugs; 2020 Jun; 25(2):101-112. PubMed ID: 32253941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the physiopathology and therapeutic management of cholestatic pruritus in children.
    Thébaut A; Debray D; Gonzales E
    Clin Res Hepatol Gastroenterol; 2018 Apr; 42(2):103-109. PubMed ID: 29031874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.